1687 related items for PubMed ID: 14973517
1. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[Abstract] [Full Text] [Related]
2. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
Guerrero P, Fuchs FD, Moreira LM, Martins VM, Bertoluci C, Fuchs SC, Gus M.
Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
[Abstract] [Full Text] [Related]
3. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
Gleim GW, Rubino J, Zhang H, Shahinfar S, Soffer BA, Lyle PA, Littlejohn TW, Feig PU.
Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
[Abstract] [Full Text] [Related]
4.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
5. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y, Neutel JM, Schumacher H.
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[Abstract] [Full Text] [Related]
6. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
Roca-Cusachs A, Schmieder RE, Triposkiadis F, Wenzel RR, Laurent S, Kohlmann O, Fogari R, MORE Study Group.
J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
[Abstract] [Full Text] [Related]
7. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[Abstract] [Full Text] [Related]
8. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[Abstract] [Full Text] [Related]
9.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
10. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E, Bombelli M, Cerasola G, Cipollone F, Ferri C, Grazioli I, Leprotti C, Mancia G, Melzi G, Mugellini A, Mulè G, Palasciano G, Salvetti A, Trimarco B.
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[Abstract] [Full Text] [Related]
11. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
[Abstract] [Full Text] [Related]
12.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
13. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[Abstract] [Full Text] [Related]
14.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
15. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
Radauceanu A, Boivin JM, Bernaud C, Fay R, Zannad F, CIC General Practitioners Investigators' Group.
Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
[Abstract] [Full Text] [Related]
16. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[Abstract] [Full Text] [Related]
17.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
18. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[Abstract] [Full Text] [Related]
19.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
20. Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population.
Franco RJ, Goldflus S, McQuitty M, Oigman W, Valsartan/HCTZ Combination Therapy in Brazil Study Group.
Blood Press Suppl; 2003 Dec; 2():41-7. PubMed ID: 14761076
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
